you are here: HomeNewsBusiness

#CoronaHaaregaIndiaJeetega | RIL to pay contract staff earnings less than Rs 30,000 even if they do not work

The company announced a number of measures, including ramping up production capacity to 1 lakh face masks per day, free fuel to emergency vehicles carrying COVID-19 patients and free meals in various cities to support the livelihood of those impacted by the outbreak

March 24, 2020 / 10:25 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reliance Industries on March 23 said it will continue to pay contract and temporary workers, even if work has halted due to this novel coronavirus, or COVID-19, outbreak. "For those earning below Rs 30,000 per month, salaries will be paid twice a month to protect their cashflow and mitigate any overwhelming financial burden," it said in a statement.

The company announced a number of measures, including ramping up production capacity to 1 lakh face masks per day, free fuel to emergency vehicles carrying COVID-19 patients and free meals in various cities to support the livelihood of those impacted by the outbreak.

In a statement, RIL said its CSR arm - Sir HN Reliance Foundation Hospital – in collaboration with the Brihanmumbai Municipal Corporation (BMC) has set up a dedicated 100-bed centre at Seven Hills Hospital, Mumbai, for patients who test positive for COVID-19. It has also built a fully-equipped isolation facility in Lodhivali, Maharashtra, and handed it over to the district authorities, as an initiative to battle against the outbreak.

To catch all the live action on the coronavirus pandemic, click here

RIL will provide free fuel for all emergency service vehicles used to transport COVID-19 patients while Reliance Foundation will provide free meals across various cities to those whose livelihood has been hit by the outbreak.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Disclaimer: Reliance Industries Ltd is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd
Moneycontrol News
first published: Mar 24, 2020 10:19 am

stay updated

Get Daily News on your Browser
Sections